A study of pattern of use for gadolinium-based contrast agents (GBCAs) in patients undergoing contrast-enhanced magnetic resonance (CE-MR) examination - a prospective, multicentre, observational study (GBCA Observational study)

Documents

Study protocol

Initial protocol

CLA-17-01 CPR Version 1.0 18Oct2017

Updated protocol

1. CLA-17-01 CPR Version 1.5 (clean)

First published: 22/02/2024

Study results

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Composition of steering group and observers

CLA-17-01 Steering Committee composition